Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Claudepierre

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|March 7, 2013
Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohortA Tournadre, B Pereira, A Lhoste, et al.
The Journal of Rheumatology|July 24, 1998
Unusual CD3+, CD4+ large granular lymphocyte expansion associated with a solid tumorP Claudepierre, P Bergamasco, M H Delfau, et al.
Neurology|August 26, 1998
Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathiesR K Gherardi, J P Farcet, A Créange, et al.
Arthritis Care & Research|January 21, 2012
Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational surveyF Canouï-Poitrine, F Kemta Lekpa, V Farrenq, et al.
Rheumatology (Oxford, England)|November 8, 2002
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyM Breban, E Vignon, P Claudepierre, et al.
The Journal of Rheumatology|October 23, 1997
Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathyP Claudepierre, J Sibilia, P Goupille, et al.
The British Journal of Dermatology|April 14, 2019
PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimensJ Gottlieb, M Madrange, C Gardair, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2018
Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'E Audureau, F Roux, D Lons Danic, et al.
The Journal of Rheumatology|October 21, 1998
Factors linked to disease activity in a French cohort of patients with spondyloarthropathyP Claudepierre, J Sibilia, F Roudot-Thoraval, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|March 7, 2013
Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohortA Tournadre, B Pereira, A Lhoste, et al.
The Journal of Rheumatology|July 24, 1998
Unusual CD3+, CD4+ large granular lymphocyte expansion associated with a solid tumorP Claudepierre, P Bergamasco, M H Delfau, et al.
Neurology|August 26, 1998
Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathiesR K Gherardi, J P Farcet, A Créange, et al.
Arthritis Care & Research|January 21, 2012
Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational surveyF Canouï-Poitrine, F Kemta Lekpa, V Farrenq, et al.
Rheumatology (Oxford, England)|November 8, 2002
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyM Breban, E Vignon, P Claudepierre, et al.
The Journal of Rheumatology|October 23, 1997
Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathyP Claudepierre, J Sibilia, P Goupille, et al.
The British Journal of Dermatology|April 14, 2019
PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimensJ Gottlieb, M Madrange, C Gardair, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2018
Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'E Audureau, F Roux, D Lons Danic, et al.
The Journal of Rheumatology|October 21, 1998
Factors linked to disease activity in a French cohort of patients with spondyloarthropathyP Claudepierre, J Sibilia, F Roudot-Thoraval, et al.
Pageof 6